Growth failure is a common problem in children with chronic kidney disease (CKD). The causes are multifactorial and are associated with increased mortality and morbidity. Standard deviations of bone age versus chronological age in children with CKD have not been developed to date. Accurate and early treatment of bone age is an important component of determining the utility of GH therapy. Improvements in bone age assessments are being evaluated to optimize the understanding of growth delay in CKD.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00467-015-3103-9 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!